Philip K. Yachmetz, SVP, General Counsel at SAVIENT PHARMACEUTICALS INC (SVNT), sold 5,418 shares at $13.31 ($72K) on 2009-12-09, disclosed to the SEC on 2009-12-10.
Scheduled sale ($72k) by SVP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |